FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123405274> ?p ?o ?g. }

• W2123405274 endingPage "e89" @default.
• W2123405274 startingPage "e85" @default.
• W2123405274 abstract "This is the first of four articles summarizing presentations at the seventh World Congress on the Insulin Resistance Syndrome, held in San Francisco, California, on 5–7 November 2009. This article pertains to cardiovascular disease (CVD) concepts.Yehuda Handelsman (Tarzania, CA), chair of the International Committee for Insulin Resistance, “revisited” the treatment of insulin resistance, discussing aspects of the metabolic findings of BARI-2D's insulin-sensitizing versus insulin-providing strategy comparison (1). “When it came to the control of glucose,” he said, “the group that was on sensitizers had a 0.5% improvement in A1C,” similar to that seen in PROactive (2). “We've seen [in RECORD (3) and ADOPT (4)],” he continued, “that if you are on sulfonylurea or metformin you lose control” whether on combination or single-agent treatment in comparison to the stability of glycemia with rosiglitazone. Furthermore, Handelsman pointed out that in BARI-2D, those undergoing CABG had better outcome with the insulin-sensitizing strategy.Reviewing the concept of metabolic syndrome, which has been defined and redefined many times since first proposed as Syndrome X by Reaven (5), Handelsman emphasized the potential benefit of thiazolidinediones, but suggested that the flawed Nissen metaanalysis of rosiglitazone (6) has led to the misperception that insulin resistance treatment is not of benefit. He asked, “Should we treat insulin resistance pharmacologically?” If there is little evidence that treatment of the syndrome is effective beyond the benefit of treatment of the components, then we may need more data to justify insulin sensitizer administration outside of diabetes treatment. It may, however, be the case that insulin levels per se can be used in guiding pharmacologic treatment, and Handelsman reviewed the evidence that pioglitazone did reduce CV event rates in subset analyses of PROactive. Insulin resistance treatment appears of benefit in the polycystic ovary syndrome (PCOS), and in nonalcoholic fatty liver disease (NAFLD), …" @default.
• W2123405274 created "2016-06-24" @default.
• W2123405274 creator A5019970806 @default.
• W2123405274 date "2010-06-29" @default.
• W2123405274 modified "2023-09-23" @default.
• W2123405274 title "2009 World Congress on the Insulin Resistance Syndrome: Cardiovascular Disease Concepts" @default.
• W2123405274 cites W1966307362 @default.
• W2123405274 cites W1967724716 @default.
• W2123405274 cites W1980717583 @default.
• W2123405274 cites W1991403690 @default.
• W2123405274 cites W1993975599 @default.
• W2123405274 cites W2001341988 @default.
• W2123405274 cites W2013956413 @default.
• W2123405274 cites W2018651068 @default.
• W2123405274 cites W2020019411 @default.
• W2123405274 cites W2025755388 @default.
• W2123405274 cites W2026387613 @default.
• W2123405274 cites W2027702390 @default.
• W2123405274 cites W2031637294 @default.
• W2123405274 cites W2048908649 @default.
• W2123405274 cites W2053585701 @default.
• W2123405274 cites W2066719367 @default.
• W2123405274 cites W2072863412 @default.
• W2123405274 cites W2076395750 @default.
• W2123405274 cites W2081276121 @default.
• W2123405274 cites W2100089051 @default.
• W2123405274 cites W2101333957 @default.
• W2123405274 cites W2101573428 @default.
• W2123405274 cites W2107085384 @default.
• W2123405274 cites W2115285670 @default.
• W2123405274 cites W2127125241 @default.
• W2123405274 cites W2128662796 @default.
• W2123405274 cites W2131490500 @default.
• W2123405274 cites W2132519575 @default.
• W2123405274 cites W2135319342 @default.
• W2123405274 cites W2138058610 @default.
• W2123405274 cites W2145053281 @default.
• W2123405274 cites W2148521985 @default.
• W2123405274 cites W2155168556 @default.
• W2123405274 cites W2159969745 @default.
• W2123405274 cites W2161844490 @default.
• W2123405274 cites W2163376944 @default.
• W2123405274 cites W2164212234 @default.
• W2123405274 cites W2164324917 @default.
• W2123405274 cites W2169226612 @default.
• W2123405274 cites W2169387542 @default.
• W2123405274 cites W2188846692 @default.
• W2123405274 cites W2271771390 @default.
• W2123405274 cites W2275139239 @default.
• W2123405274 cites W2337454357 @default.
• W2123405274 doi "https://doi.org/10.2337/dc10-zb07" @default.
• W2123405274 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2890386" @default.
• W2123405274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20587709" @default.
• W2123405274 hasPublicationYear "2010" @default.
• W2123405274 type Work @default.
• W2123405274 sameAs 2123405274 @default.
• W2123405274 citedByCount "2" @default.
• W2123405274 countsByYear W21234052742012 @default.
• W2123405274 crossrefType "journal-article" @default.
• W2123405274 hasAuthorship W2123405274A5019970806 @default.
• W2123405274 hasBestOaLocation W21234052741 @default.
• W2123405274 hasConcept C126322002 @default.
• W2123405274 hasConcept C134018914 @default.
• W2123405274 hasConcept C177713679 @default.
• W2123405274 hasConcept C2777391703 @default.
• W2123405274 hasConcept C2779134260 @default.
• W2123405274 hasConcept C555293320 @default.
• W2123405274 hasConcept C71924100 @default.
• W2123405274 hasConceptScore W2123405274C126322002 @default.
• W2123405274 hasConceptScore W2123405274C134018914 @default.
• W2123405274 hasConceptScore W2123405274C177713679 @default.
• W2123405274 hasConceptScore W2123405274C2777391703 @default.
• W2123405274 hasConceptScore W2123405274C2779134260 @default.
• W2123405274 hasConceptScore W2123405274C555293320 @default.
• W2123405274 hasConceptScore W2123405274C71924100 @default.
• W2123405274 hasIssue "7" @default.
• W2123405274 hasLocation W21234052741 @default.
• W2123405274 hasLocation W21234052742 @default.
• W2123405274 hasLocation W21234052743 @default.
• W2123405274 hasLocation W21234052744 @default.
• W2123405274 hasOpenAccess W2123405274 @default.
• W2123405274 hasPrimaryLocation W21234052741 @default.
• W2123405274 hasRelatedWork W1979252938 @default.
• W2123405274 hasRelatedWork W2032225465 @default.
• W2123405274 hasRelatedWork W2044823377 @default.
• W2123405274 hasRelatedWork W2169206971 @default.
• W2123405274 hasRelatedWork W2378290744 @default.
• W2123405274 hasRelatedWork W2584731720 @default.
• W2123405274 hasRelatedWork W2886303208 @default.
• W2123405274 hasRelatedWork W2910989958 @default.
• W2123405274 hasRelatedWork W2969331335 @default.
• W2123405274 hasRelatedWork W3028840175 @default.
• W2123405274 hasVolume "33" @default.
• W2123405274 isParatext "false" @default.
• W2123405274 isRetracted "false" @default.
• W2123405274 magId "2123405274" @default.
• W2123405274 workType "article" @default.